Roote Prokop SupplMat 1v3.3
Roote Prokop SupplMat 1v3.3
Roote Prokop SupplMat 1v3.3
10
4.1.2. Alleles
10
12
13
16
17
5. Transgenic flies
19
19
21
21
22
22
d. Gal4/UAS lines
23
e. FRT lines
24
f. RNAi lines
24
25
25
b. Meiotic mapping
25
Updated versions of this document can be downloaded @ dx.doi.org/10.6084/m9.figshare.106631 and a lite version
for short term training @ dx.doi.org/10.6084/m9.figshare.156395
c. Deletion mapping
26
27
28
8. Acknowledgements
29
9. References
29
Boxes
Box 2. Concepts for genetic research: forward versus reverse genetics & LOF versus GOF
11
14
18
28
Figures
Fig. 2 A typical flow diagram of how genetic screens in Drosophila contribute to research
10
Fig. 6. Independent assortment of alleles & comparison of recessive and dominant inheritance
12
13
15
16
17
19
20
22
Fig. 14. The versatile Gal4/UAS system for targeted gene expression
23
24
25
26
27
Appendix
33
35
Drosophila's enormous success originates from the numerous practical advantages this tiny insect
and the community of fly researchers have to offer to the experimenter. The most important
2 3
advantages are briefly listed below (and tongue-in-cheek here) & :
Fruit flies are easy and cheap to keep. High numbers of different fly stocks can be kept in a
handful of laboratory trays, thus facilitating high-throughput experiments and stock
management (section 3).
A fruit fly generation takes about 10 days (Fig.1), thus fly research progresses rapidly and
pedigrees over several generations can be easily planned and monitored.
The fly genome is of low redundancy, i.e. only one or very few genes code for members of
one protein class. In contrast, higher organisms tend to have more paralogous genes
encoding closely related proteins that often display functional redundancy and complicate
loss-of-function analyses.
A particular strength of Drosophila is the possibility to perform unbiased screens for genes
that regulate or mediate biological processes of interest, often referred to as forward genetics
(Fig. 2; Box 2). Highly efficient and versatile strategies have been developed that can be
adapted to the experimenter's needs [17,42,53,91,94].
Virtually every gene of Drosophila is amenable to targeted manipulations through a wide
range of available genetic strategies and tools, ideal to perform reverse genetics (Box 2).
1
2
for an excellent overview of Drosophila genetics see the appendix of the book by Hartwell [49] (http://highered.mcgrawhill.com/sites/007352526x/student_view0/genetic_portrait_chapters_a-e.html)
3
Informative lay descriptions of fly research can be found on the Wellcome Trust Blog:
The portrait of a fly (Part 1) - wellcometrust.wordpress.com/2012/11/20/feature-the-portrait-of-a-fly-part-1/
The portrait of a fly (Part 2) - wellcometrust.wordpress.com/2012/11/23/the-portrait-of-a-fly-part-2-fly-on-the-wall/
Experimental manipulations and observations of cells and tissues in vivo are relatively easy.
Thus, organs are of relatively low complexity and size, and can usually be studied live or via
straightforward fixation and staining protocols in the whole organism. Only in exceptional
cases are these experiments subject to legal requirements or procedures, thus enormously
facilitating the fast implementation of experimental ideas. Furthermore, there is a "parallel
universe" of complementary Drosophila research in cell culture. Firstly, an impressive number
of Drosophila cell lines is readily available (dgrc.cgb.indiana.edu/cells/Catalog), of which
especially S2 cells have achieved considerable recognition beyond the community of fly
researchers [29]. Secondly, primary cell cultures (cells directly harvested from the organism)
are well established, especially for neurons and haemocytes [81,88], and offer important
complementary readouts amenable to the full range of versatile Drosophila genetics.
Finally, more than a century of fly work has produced a huge body of knowledge and a rich
resource of genetic tools. From early days of Drosophila genetics up to this day, the fly
community has maintained a highly collaborative spirit which facilitates research enormously
through generous exchange of materials and information [59,60]1. Well organised databases
and stock centres provide easy access to knowledge, fly strains and materials, all of which are
well integrated and curated in FlyBase (flybase.org) the central point of reference for fly
researchers worldwide [73,93] 2.
Box 2. Concepts for genetic research: forward versus reverse genetics & LOF versus GOF
Gene manipulations are generally employed to serve two principal strategies: forward and reverse
genetics [92]. FORWARD GENETICS is the approach to identify the genes that are responsible for a
particular biological process or function. In Drosophila, this is usually performed through using unbiased
large-scale screens for genetic aberrations that disturb the process/function in question, and the
subsequent identification of the genes affected through these aberrations (Fig. 2). REVERSE
GENETICS is the approach to unravel the functions behind specific genes of interest, for example when
trying to understand molecular mechanisms or functions of genes known to cause human disease (using
the fly as a "test tube"). For this, loss- or gain-of-function (LOF, GOF) approaches are employed, using
existing mutant alleles and a wide range of transgenic fly lines that are often readily available (Box 3).
GOF approaches attempt to obtain functional information by creating conditions where the gene is
excessively or ectopically expressed or its function exaggerated. This can be achieved through classical
GOF mutant alleles (section 4.1.2) or through targeted expression of genes, either of their wild type
alleles or of constitutive active versions (section 5).
LOF approaches attempt to eliminate a genes function partially or completely. This can be achieved
by employing classical LOF mutant alleles (section 4.1.2), transposable element insertions (existing for
virtually all gene loci; section 5.2b-d), knock-down of genes using RNA interference strategies (readily
available as transgenic lines for virtually every gene; section 5.2f), the targeted expression of dominantnegative constructs (e.g. catalytically dead versions of enzymes titrating out the function of the
endogenous healthy enzyme), or the use of targeted expression of single domain antibodies (Box 3).
Furthermore, there are constantly improving strategies for the manipulation of genes in situ, i.e. in their
chromosomal location, including...
classical mutagenesis strategies in which mutations are first generated at random and then selected
over chromosomal deficiencies uncovering the targeted gene, thus enriching for candidate mutant
alleles of this gene (section 6c)
generation of targeted deletions at the gene locus through recombinase-mediated mobilisation or
homologous recombination of local transposable elements (section 5.1)
targeted manipulations of the gene locus through genomic engineering, using recombinase-based
strategies [52], TALEN strategies (transcription activator-like effector nuclease) [62,68] or CRISPR
technology (clustered regularly interspaced palindromic repeats) strategies [7,43].
All issues of the legendary Drosophila Information Service can be browsed here: www.ou.edu/journals/dis/
fly media recipies: Bloomington / Fly Work / Media recipies and for efficient storage see here
A) Fly stocks are stored in large numbers on trays in temperature controlled rooms/incubators (the trays
shown here each hold two copies of 50 stocks). B) Each fly stock is kept in glass or plastic vials which
contain food at the bottom and are closed with foam, cellulose acetate, paper plugs or cotton wool. Larvae
live in the food and, at the wandering stage, climb up the walls (white arrow) where they subsequently
pupariate (white arrow head). C-E) To score for genetic markers and select virgins and males of the
desired phenotypes, flies are immobilised on CO 2-dispensing porous pads (E), visualised under a
dissecting scope (C, D) and then discarded into a morgue or transferred to fresh vials via a paint brush,
2
forceps or pooter / aspirator (C, E). For further information on how a typical fly laboratory is organised see
3
other sources [3,4,5,95] .
Box 4. Keeping information about laboratory stocks
Work in a fly laboratory involves constant influx of new fly stocks, although only a small percentage of
these will eventually be kept in your stock collection. Follow good practice by making it a rule to instantly
document the essential information for each incoming stock in a dedicated folder or data sheet/base
before it gets lost and forgotten in daily routine:
1. Keep the full original genetic description and any other information you may find on vials or
accompanying notes (e.g. stock centre references or other seemingly meaningless numbers). Note
that genetic descriptions you are given by the donor may be incomplete, and your accessory notes
may provide unique identifiers for this fly stock when communicating with the donor laboratory.
2. Note down the donor laboratory/person and contact. You will need this information for further
enquiries and acknowledgements in future publications.
3. When introducing stocks into your collection, transfer the above information into the accompanying
data base/sheet. Make sure there is a proper genetic description, a clearly assigned short hand for
daily use, info on the donor and the key reference publication. This information will be most useful
when writing up your project and for people succeeding you in the laboratory.
Stock keeping is usually done at 18C (generation time of about 1 month). It is good practice to
keep one young and one two week older vial of each stock. Every fortnight, freshly hatched flies
from the month-old vial are flipped into a fresh vial, whilst the two-week-old vial should have
produced larvae and serves as back-up. Such a routine allows you to spot any problems on
time, such as infections (mites, mould, bacteria, viral infections) [3], the need to add water (if the
food is too dry and coming away from the wall) or to reduce humidity (if vials are too moist so
that fungus accumulates and/or flies get stuck in the food and at walls).
Experiments with flies tend to take place at room temperature or at certain conventional
temperatures, such as 25C for well-timed experiments or 29C to speed up development or
enhance targeted gene expression with the Gal4/UAS system (section 5.2).
1
Incubators need to be fly-proof: copper is aggressively corroded in the presence of flies and should be replaced by
stainless steel or needs at least to be well protected (e.g. thoroughly coated with resin).
2
for use & construction of pooters see: files.figshare.com/1417904/PootersForDrosophilaGenetics_v2_1.pdf
3
gender choice is an option, choose males from the morbid stock/genotype and females from the
more viable stock/genotype to enhance your chances of establishing the next generation.
Furthermore, make sure that you improve the yield of these morbid flies by taking a number of
measures:
Avoid over-population of vials, which tends to negatively select against morbid individuals. For
this, transfer parents to new vials when sufficient eggs have been laid (within a time frame of 1
day to 1 week, depending on the fertility of stocks used and numbers of parental flies).
Morbid flies tend to get stuck and lost in the food. Therefore monitor crosses daily from start of
eclosion, even if you want to collect only males. Alternatively you may resort to gender scoring
at the larval or pupal stage (Box 5).
Morbid animals tend to hatch late. For example, males carrying the balancer chromosome FM7
(Fig. 11) tend to eclose days after their heterozygous female siblings. Therefore, continue
scoring for as long as possible, but stop and discard the tube before potential individuals of the
grandchild generation start emerging (after ~19 d in a modestly populated tube at 25C).
Make sure that strains are free of bacterial or viral diseases as well as fungal or mite infection
[3]. These conditions can pose a threat to the feasibility of mating schemes. The best
prophylaxis is careful and regular husbandry of your fly stocks.
Note that these same measures should also be taken when you need to quantitatively assess the
relative abundance of different phenotypes emerging from a cross. This is required, for example,
when carrying out meiotic mapping experiments (section 6b), or when you want to perform geno/phenotypic counts of homozygous mutant versus heterozygous/balanced animals, in order to
determine the degree of lethality as a measure of allelic strength. In these cases you need to take
care that morbid animals are not disadvantaged by the stock keeping and harvesting prodecures.
Box 5. How to select flies
Early drosophilists commonly used ether to select flies for gender and phenotypic markers. Nowadays
flies are tipped from their vials onto porous pads dispensing CO2 which acts as a narcotic and is not
harmful if exposure is kept to a few minutes (www.youtube.com/watch?v=S7FkmBjrnAs). Using a
dissection microscope, flies can be easily inspected and selected on this pad (Fig. 3C-E):
Small numbers of flies are efficiently selected using a pooter/aspirator, which is a simple rubber tube
with a mouth piece at one end and glass pipette at the other (Fig. 3C, E and footnote 2 on page 7). A
pooter is far more efficient than a paint brush, since flies can be simultaneously selected and collected
and then directly be blown into vials, even if these already contain flies.
When scoring large numbers of flies, arrange them into a line across the pad and pull out one
phenotypic class at a time. In this way you only have 2 piles of flies on the pad at any one time. Note
that a simple iPhone App can be used to count flies efficiently. Use a funnel to tip the selected flies
from the pad into vials. Note that large-scale virgin collection can be automated using stocks carrying
inducible lethal factors on the Y chromosome [see l(2)DTS in Box 8].
Morbid fly stocks/crosses do not tolerate overnight storage at lower temperatures (used to guarantee
virginity of eclosed individuals in the morning) very well. To maximise yields, individuals can be sexed
as larvae or pupae [32], removed from their tubes with a wet paint brush, and transferred into vials
separated by gender. After eclosion, flies can be screened for phenotypic markers.
Especially in complex mating schemes involving multiple markers, a safe way of phenotype and
gender selection is to merely separate males from females into distinct vials during your daily routine.
Only when enough animals have been collected, perform the marker selection in one single session.
This mode is safer and less time-consuming, especially for the inexperienced fly pusher or when
various crosses are running in parallel so that keeping an overview becomes a challenge.
Selected flies are added to fresh standard vials properly labelled with gender and genotype (Fig. 3B) and
kept at your temperature of choice. Non-selected flies are disposed of in a fly morgue (usually a bottle
containing 70% alcohol) and never returned to their vials of origin.
10
4.1.2. Alleles1
Genes exist in different alleles. Most loss-of-function mutant alleles (hypo- or amorphic/null) are
recessive. Their phenotypes are not expressed in heterozygous (-/+) but only in homozygous
animals (-/-), i.e. the wildtype allele mostly compensates for the functional loss of one gene copy
(see w, vg or e in Fig. 6). Loss-of-function mutant alleles can also be dominant. For example,
phenotypes are observed in animals heterozygous for Ultrabithorax (Ubx/+), Polycomb (Pc/+), or
Notch (N/+) loss-of-function alleles, i.e. the wildtype allele is insufficient to compensate for loss of
one functional gene copy (haplo-insufficiency). Dominant alleles can also be gain-of-function,
usually caused by over-expression of a gene product (hypermorph or "dominant negative"
antimorph) or by ectopic expression or activation of a gene product, potentially conveying novel
gene functions (neomorph). For example, BarH1 over-expression in the eye causes kidney-shaped
eyes in Bar1/+ individuals (Fig. 6) [61], ectopic Antp expression in antennae the antenna-to-leg
transformations in Antp73b/+ (Fig. 9) [41], and Krppel mis-expression the reduced eyes in If1/+
animals (Fig. 9) [23]. Dominant alleles may display intermediate inheritance showing a stepwise
increase in phenotype strength from heterozygous to homozygous animals. Thus, the eyes of
heterozygous flies (B1/+) are kidney-shaped, whereas they display a stronger slit-shaped phenotype
in homo- (B/B) or hemizygous (B/Y) flies (Fig. 6). Animals carrying the loss-of-function mutant allele
abd-AMX1 in heterozygosis are viable and show a weak dominant cell proliferation phenotype,
whereas homozygous animals are lethal and show a strong cell proliferation phenotype [80]. Note,
that the phenotype distribution in pedigrees involving dominant mutant alleles differs from those
with recessive mutant alleles (Fig. 6). Also note that the existence of dominant and recessive alleles
has impacted on gene names (capitalisation of the first letter), which can be confusing or even
misleading (Box 7). As a further matter of complication, a phenotype you observe may not always
be caused by the gene or mutant allele you believe to study, but a whole range of potential
independent factors in the background of your fly stock/cross might modify the strength or quality of
the observed phenotype, or be causing the whole phenotype all together. Be aware of this and
carry out appropriate control experiments before drawing hasty conclusions (Box 6).
1
11
12
Figure 6. Independent assortment of alleles & comparison of recessive and dominant inheritance
Two examples of crosses between heterozygous parents (P) involving recessive alleles (top left) and a
dominant allele (green box top right) are shown. Homologous alleles are separated by a horizontal line;
maternal alleles are shown in black, paternal ones in blue. Mutant alleles are w (white; white eyes), vg
(vestigial; reduced wings), B (Bar; reduced eyes); phenotypes are indicated by fly diagrams (compare Fig.
9). When comparing inheritance of the eye marker mutations w (left) and B (right), it becomes apparent
that the allele assortments are identical, yet only the heterozygous B mutant females show an intermediate
eye phenotype.
nd
The left example is a dihybrid cross involving mutant alleles on X and 2 chromosomes (separated
by semicolons). In the first offspring/filial generation (F1) each chromosome has undergone independent
assortment of alleles (demarcated by curly brackets) and each of the four possible outcomes per
chromosome can be combined with any of the outcomes of the other two chromosomes resulting in 4 x 4 =
16 combinations. In case of two autosomal genes, the phenotypic distribution would be 9:3:3:1 (9 white : 3
blue : 3 yellow : 1 pink coloured fields in the Punnett square), as compared to 3:1 in a monohybrid cross
(vg/+ X vg/+ only one of 4 animals displays vg phenotype). In the above cross, w is X-chromosomal
which changes the phenotypic distribution to 6:6:2:2 (6 white : 6 plain/hatched blue : 2 yellow : 2
plain/hatched pink in the Punnett square). The Punnett square lists all possible combinations (symbols
explained on the right); red and blue stippled boxes in the curly bracket scheme and Punnett square show
the same examples of two possible offspring. Note that the Punnett square reflects the numerical outcome
of this cross in its full complexity, whereas the curly bracket strategy only qualitatively reflects potential
combinations and is easier to interpret for the purpose of mating scheme design (Box 9). The complexity of
Punnett squares becomes even more obvious when dealing with trihybrid crosses (Appendix 2).
13
harbours very few genes and its genetics slightly differs from other chromosomes [46]. It plays a
negligible role in routine fly work and will therefore not be considered here.
4.1.4. Linkage groups and recombination
Genes located on the same chromosome are considered a linkage group that tends to segregate
jointly during meiosis. However, when homologous chromosomes are physically paired during
meiotic prophase (synapsis), the process of intra-chromosomal recombination (crossing-over)
can lead to exchange of genetic material between homologous chromosomes (Fig. 7; note, that
recombination does not occur on the 4th chromosome). As a rule of thumb, the recombination
frequency increases with distance between gene loci, but non-uniformly across the chromosome
arms (map expansion/compression). Frequencies are usually high in the middle of chromosome
arms and low in regions adjacent to heterochromatin-rich telomeres and centromeres.
Recombination frequencies have been used to generate spatial chromosomal maps of gene loci
(recombination maps), defining 1% chance of crossing-over between two loci as 1 map unit (or
centimorgan, cM) [46]1. 50% is the maximum detectable crossing-over frequency because crossingover is happening at the 4-strand stage; only 2 strands are involved in any one event and exchange
between sister chromatids produces no observable changes. If two genes are 50 cMs apart then
they are equivalent to being unlinked (due to the increase in multiple crossing-over events occurring
between them). If the location of two loci is known relative to the cytogenetic map, their position on
the recombination map can be roughly estimated and the recombination frequency between them
deduced (Fig. 7B and bottom of Box 7).
14
crossing-over in Drosophila males (Fig. 7). The reason for this is not clear but might relate
to the observation that, the type of genes expressed in male meiosis "is much more similar to
mitosis than to female meiosis" [106], albeit reductional divisions occur and haploid gametes
are produced.
Box 7. Gene descriptors and locators
Drosophila genes have different descriptors: name, symbol, synonyms, the annotation symbol and
the FlyBase ID. As an example, go to the FlyBase home page flybase.org. In the "Quick Search" box
click on the "Data Type" tab, select "Data Class / genes" and type "shot" into the text field. This will
direct you to the gene page where you will find a full description of the gene short stop including
various identifiers and locators in the top section and further synonyms in the second last bottom
section [e.g. kakapo/kak, groovin/grv, kopupu/kop, l(2)CA4]. The naming of genes and chromosomal
aberrations follows agreed rules (FlyBase / Documents / Nomenclature), as summarised here:
o The names of Drosophila genes (and their associated short forms or symbols) reflect the
classical (and certainly most human) way to describe a gene or marker mutation. They are
most commonly used in daily life and publications and tend to reflect the mutant phenotypes of
genes - often in very creative ways (e.g. faint sausage, ether-a-gogo, couch potato). For
example, white loss-of-function mutations cause white eyes, indicating that white gene function
is normally required for red eye colour. However, not everybody has followed this tradition when
naming genes. Furthermore, mutations of genes which were identified as homologues to known
mouse or human genes tend to be named after their mammalian relatives. Note that genes
encoding products of similar molecular function may be given names/symbol with identical
prefixes (usually indicating the protein class) and unique suffixes (usually referring to a gene's
cytogenetic location; e.g. Actin-5C, Actin-42A, Actin-57B). For an entertaining radio feature
about fly names listen to www.bbc.co.uk/programmes/b00lyfy1.
o As illustrated by the shot example, genes have often been called differently by independent
researchers (Synonyms & Secondary IDs), and these names come with their independent
symbols. FlyBase usually follows the rule that the first published name for a mutation of a gene
(usually not the wildtype locus or protein) becomes official, but a searchable list of all
synonymous names is maintained. In any case, FlyBase is your key point of reference and you
are advised to use their official naming.
o The annotation symbol (CG number, the Computed Gene identifier) originates from the
genome sequencing projects and has only been assigned to genetic loci that have been
identified as genes. For example, Cy/Curly is a mutation of unknown molecular nature and has
therefore no CG number. CG numbers are primarily used if no other name has been given yet.
o The FlyBase ID (FBgn = FlyBase gene) is the only unique identifier available for both
annotated genes and non-annotated marker mutations. It is often the prime reference during
database searches.
As a general convention, genes/symbols that were FIRST named after recessive mutant alleles
(section 4.1.2) start with lower case, those FIRST identified by dominant alleles are capitalised. For
example, abd-A is lower case due to its original classification as a recessive gene, although
subsequent analyses have revealed dominant loss-of-function mutant phenotypes [80]. Capitalisation
can be confusing, since identical symbols starting with either upper or lower case represent different
gene or marker names (e.g. syn/syndrome versus Syn/Synapsin). Furthermore, genes named after
vertebrate homologues are capitalised, regardless of whether their mutant alleles are dominant or
recessive (e.g. Nrx-IV /Neurexin IV or Syn/Synapsin).
-
Be aware that short hand for mutant alleles in daily use can differ. For example, "w;+;+" or "w" or "w "
or "w /w " all mean the same thing, i.e. a white mutant fly. Whereas the first two versions do not
discriminate gender, the fourth option clearly indicates a female.
Note that genes and their mutant alleles are usually italicised, whereas proteins are written in plain
sf20
and often capitalised (the shot gene, the shot
mutant allele, the Shot protein)
The genomic location of a gene is given in up to 4 ways: the chromosome (arm), cytogenetic map
position (both Fig. 5), the sequence location within the fully sequenced Drosophila genome and, for
marker mutations, also the recombination map position (e.g. the shot gene is on chromosome arm
2R, in cytogenetic map position 50C6-50C9, in sequence location 2R:9,751,742..9,829,615
corresponding to the recombination map position 2-[68]). Use the "Map Conversion Table"
(importable in Excel) for determining recombination map positions of other genes (section 4.1.4).
15
16
Photos of flies carrying marker mutations have been published elsewhere [30,32] .
see also images available on FlyBase or as an App, or download the poster "Learning to Fly".
available on FlyBase at the bottom of "Summary Information" for genes that were listed in the red book
17
phenotypes reveal about the normal gene function). On the other hand these mutations provide
important markers to be used during genetic crosses and, hence, for mating scheme design. A few
marker mutations commonly used for fly work are illustrated in Fig. 9.
18
chromosome and the products of any recombination that does occur are lethal due to duplications
and deletions of chromosome fragments (aneuploidy of chromosome fragments). The cytological
order of breakpoints for each balancer is listed on the Bloomington site (Balancers / Inversion
breakpoints present on balancers) and shown as pictograms in THE ATLAS [32], nicely illustrating
the weak spots where balancers are prone to recombination (asterisk in Fig. 10A). In addition, most
balancer chromosomes are lethal in homozygosis. Together these properties are essential for
stock maintenance, since they eliminate all genotypes that differ from the parental combination (Fig.
10B). First chromosomal balancers (FM7, first multiply-inverted 7) are usually viable in homo- or
hemizygosis, but carry recessive mutations such as snX2 and lzs that cause female sterility in
homozygosis. The principal outcome for stock maintenance is the same (Fig. 11). The third key
feature of balancer chromosomes is the presence of dominant and recessive marker mutations.
Through their dominant marker mutations, balancer chromosomes are easy to follow in mating
schemes. For example, by making sure that a recessive mutant allele of interest is always kept over
dominantly marked balancers, the presence of this allele can be "negatively traced" over the various
generations of a mating scheme - especially since recombination with the balancer chromosomes
can be excluded. Examples of balancer chromosomes are listed in Box 8.
Box 8. Examples of balancer chromosomes
Numerous balancer stocks are available from Drosophila stock centres (e.g. Bloomington / Balancers):
Typical standard balancers (most marker mutations explained in Fig. 9):
a
1
o FM7a (1st multiply-inverted 7a) - X chromosome - typical markers: y, w , sn, B
st
1
o FM7c (1 multiply-marked 7c) - X chromosome - typical markers: y, sc, w, oc, ptg, B
nd
o CyO (Curly derivative of Oster) - 2 chromosome - typical markers: Cy (Curly), dp (dumpy;
2
bumpy notum), pr (purple; eye colour), cn (cinnabar; eye colour)
nd
o SM6a (2nd multiply-inverted 6a) - 2 chromosome - typical markers: al, Cy, dp, cn, sp
rd
bx-34e
o TM3 (3rd multiply-inverted 3) - 3 chromosome - typical markers: Sb, Ubx
, (bithorax; larger
halteres) e, Ser
o TM6B (3rd multiply-inverted 6B) - 3rd chromosome - typical markers: AntpHu, e, Tb (Tubby;
rd
physically shortened 3 instar larvae and pupae)
Balancers with extra features which can make your life easier:
st
nd
o most 1 and 2 chromosomal balancers carry the same dominant markers (B and Cy,
4
respectively); additional dominant markers, such as Star/S* on CyO or Lobe/L on SM1, can be
helpful to distinguish paternal and maternal balancers, e.g. in back-crosses.
o balancers may carry l(2)DTS or transgenic insertions of hs-hid (Wrinkled) constructs, which cause
cellular lethality when elevating the temperature to ~29C the individuals carrying these balancers
are automatically eliminated, thus enriching for animals homozygous for the non-balancer
chromosome. Note, that having these features on the Y chromosome can be used to collect
virgins at large scale by simply elevating the temperature during development.
o green/blue balancers carry constructs expressing GFP or -Gal, ideal to select against balanced
animals also in embryos, larvae or pupae - live or in fixed/stained preparations. However, note
that some of these balancers were generated through double-insertion of a Gal4 construct (e.g.
Kr-Gal4, twi-Gal4) and a UAS-GFP construct [24,48]; the Gal4 constructs on these balancers will
activate any other UAS-constructs kept in the same stock, thus causing potential phenotypes or
accumulation of unwanted suppressor mutations over time.
Multiple-balancer stocks carry balancers on more than one chromosome, ideal to cross together
and keep mutations / markers on different chromosomes (see also Fig. 15).
Translocation balancer stocks also carry two balancers, but these act as one balancer across
different chromosomes; large fragments have been exchanged between these balancers [e.g.
T(2;3)CyO-TM3] causing lethality in animals that do not inherit both of them.
Compound-X / attached-X chromosomes [e.g. C(1)DX] are not true balancers but can be used in
similar ways; they consist of two X chromosomes fused together so that they do not segregate during
meiosis and are jointly passed on to one gamete. Stocks are maintained by C(1)DX/Y females which
inherit the attached-X from their mothers and the Y from their fathers, whereas C(1)DX/X females
carry three X chromosomes and are lethal or sterile. The X/Y males are the only individuals passing
on the non-attached-X chromosome - ideal for maintaining dominant female sterile mutations.
19
Note that the 4th chromosome does not require balancers since it does not display
recombination. Instead the ciD mutant allele is used to maintain stocks with lethal/sterile mutations
of genes on the 4th chromosome; ciD is a recessive lethal, dominant marker mutation caused by a
chromosome rearrangement that led to a fusion protein encoded by the cubitus interruptus and pan
genes.
5. Transgenic flies
5.1. Generating transgenic fly lines
Transgenic flies have become a key resource for Drosophila genetics with many important
applications (see below). Accordingly, transgenic animals are omnipresent in mating schemes, and
it is important to understand their principal nature and some of their applications. The generation of
transgenic fly lines is based on the use of transposable elements/transposons. Transposable
elements are virus-like DNA fragments that insert into the genome fairly randomly, where they can
be maintained in position over many generations, replicate like endogenous genes and follow
Mendelian rules of inheritance. There are ~100 types of natural transposons in Drosophila
melanogaster and thousands of insertions per individual genome [56]. Transposons encode
specialised enzymes called transposases which catalyse mobilisation of the transposons into other
genomic locations, either through excision/re-integration or through replication (Fig.12A). In
Drosophila, the most frequently used class of transposon is the P-element which will be dealt with
primarily in this manual. For the purpose of transgenesis, transposons are modified genetically.
The transposase gene is removed and replaced by the genes the experimenter wants to introduce
into the fly genome, in addition to marker genes and genes/motifs for the selective cloning of the
transposable element in bacteria (Fig. 12B), as well as further potential features enhancing the use
of these constructs (section 5.2).
To introduce purpose-tailored transposons into the fly genome, they are injected into early
embryos at the syncytial blastoderm stage. Injection has to take place at the posterior pole where
the pole cells will form, which are the precursors of sperm and egg cells (Fig. 12) [6]. If successfully
integrated into the genome of some pole cells, the injected transposons will give rise to transgenic
offspring. To catalyse genomic insertion of these P-elements, injections are performed in the
presence of transposases, through using transgenic fly lines expressing transposase in the
germline, or co-injecting helper elements (Fig. 12C, D). Transgenic transposases are crossed out
in the next generation, helper elements don't integrate into the genome and get lost subsequently
(Fig. 12D). Through this disappearance of the enzymatic transposase activity, successful P-element
insertions are stabilised and can be maintained as stocks. Generating transgenic fly lines through
transposon/helper element injection requires technical expertise and specialised equipment, such
as micromanipulators and glass needle pullers. It is often more economical to outsource this task to
specialised companies (of which there are a number existing worldwide), instead of establishing
and maintaining this capacity in individual laboratories.
20
21
P[acman] clones of genes or genomic regions can be found at pacmanfly.org and are distributed at bacpac.chori.org
22
genes in their region, but they can also activate the promoters on transgenic constructs.
Therefore, to identify and characterise enhancers in (non-coding) regulatory regions of genes,
genomic fragments containing these regions can be cloned in front of a P-element promoter
(which alone is too weak to initiate gene expression) fused to a reporter gene (e.g. GFP or
lacZ/-Gal from E. coli). Transgenic animals carrying these constructs can then be analysed
for the spatiotemporal expression pattern of the reporter gene as a readout for enhancer
activity, and also be used as genetic tools to label certain tissues for experimental purposes.
A) P{Ubx-lacZ,w } illustrating an enhancer/reporter line. An enhancer element that usually activates the
promoter of the Ubx gene at cytogenetic map position 89D (light green box with right pointing arrow) is
cloned (stippled black line) into a P-element, next to a lacZ reporter gene with a basal promoter (dark box
with right pointing arrow) that alone is insufficient to drive lacZ expression. After genomic insertion
(scissors; here at cytogenetic map position 36C), Ubx-E activates (black arrow) transcription of the basal
promoter in a Ubx-like pattern translating into a Ubx-like Gal expression pattern in the transgenic flies
+
(blue). B) P{lacZ,w }Ubx illustrating an enhancer trap line. A P-element (curly bracket; colour code as in
Fig. 12) carrying lacZ with a basal promoter is inserted in the Ubx gene locus at 89D. The endogenous
Ubx-E activates expression of the lacZ gene on the P-element (blue in fly). Note that the inserted Pelement may disrupt (red stippled T) expression or function of the endogenous gene (red stippled X), thus
generating a mutant allele (red stippled arrow).
b. Enhancer trap lines (Fig. 13 B): The P-element promoter alone is too weak to initiate gene
expression of fused reporter genes. Therefore, transposable elements carrying such a Pelement promoter fusion construct will display reporter gene expression only if inserted in a
genomic site which lies within the activity range of endogenous enhancers. By generating
many random insertions of such P-elements, the genome can therefore be screened for
enhancers which are active in specific tissues at certain stages. Such activity often indicates
the presence of genes which are expressed and therefore potentially relevant in these tissues.
This procedure is referred to as an enhancer trap screen [11]. Since P-element insertions
frequently affect the function of genes at their insertion site (stippled red T in Fig. 13 B), they
can be used for systematic P-element mutagenesis screens [53] (see also Fig. 2). Once Pinduced insertions have been generated, reporter gene patterns may reveal when and where
the gene is active (Fig. 13 B), and efficient cloning strategies can be used to map the insertion
and identify the targeted gene (Fig. 12 B).
c. Protein trap lines: A protein trap screen is an advanced version of an enhancer trap screen.
It uses transposons which carry protein tag-encoding sequences (e.g. GFP) flanked by splice
acceptor and donor sites. If such a transposon inserts into an intron (within or flanking a
gene's coding region), the tag gets spliced into the host gene's natural product. This produces
tagged versions of endogenous proteins which are otherwise under their normal regulation (in
contrast to GFP-tagged proteins expressed via Gal4/UAS), so that GFP reflects their natural
expression and localisation patterns [20,58,90].
23
d. Gal4/UAS lines: Gal4 is a transcription factor from yeast that activates genes downstream of
UAS (upstream activating sequence) enhancer elements. Gal4 does not exist endogenously
in flies and does not act on any endogenous loci in the fly genome. Very many transgenic
Gal4 fly lines have been and are still being generated. To illustrate this point, the simple
search term "Gal4" produces almost 6000 hits representing individual fly stocks at the
Bloomington Stock Centre. Of these, numerous Gal4 lines are readily available that display
Gal4 expression in different tissues or cells at specific developmental stages (Fig. 14 a, b). By
simply crossing Gal4-expressing flies to UAS construct lines (Fig. 14 c, d) or enhancerpromoter (EP) lines [86] (Fig. 14 e), the genes downstream of UAS enhancers are being
activated. UAS-linked genes can be of very different nature including reporters, different
isoforms of fly genes (or of other species), optogenetic or physiological tools, small interfering
RNAs or cytotoxins (Box 3). Once crossed to a Gal4 line, the offspring will display expression
of these UAS-coupled genes in the chosen Gal4 pattern. This provides an impressively
versatile and powerful system for experimentation, the spatiotemporal pattern of which can be
further refined through technical improvements such as the use of Gal80 (a Gal4 repressor),
Split Gal4 or the use of alternative strategies (alone or in combination), such as the LexAbased binary expression system [36,40,76]. A further important feature of the Gal4/UAS
system is that its expression strength can be decreased/increased by keeping Gal4/UAS
individuals at lower (e.g. 18C)/higher (e.g. 29C) temperatures.
Figure 14. The versatile Gal4/UAS system for targeted gene expression
The Gal4/UAS system is a two component system where flies carrying Gal4-expressing constructs are
crossed to flies carrying UAS-constructs (inset). Gal4 (black knotted line) binds and activates UAS
enhancers (dotted-stippled lines), so that the pattern in which Gal4 is expressed (here ubiquitously in the
fly) will determine the expression pattern of any genes downstream of the UAS enhancer (here -Gal or
Ubx). The two components can be freely combined providing a versatile system of targeted gene
expression. For example, Gal4-expressing constructs can be enhancer construct lines (a) or enhancer
trap lines (b). The shown Gal4 lines are analogous to those in Fig. 12 with some modifications: Pelements carry Gal4 instead of lacZ, the enhancer trap line is inserted into the ubiquitously expressed
Act42A actin gene at cytogenetic map position 42A, and the enhancer element is the Act42A enhancer
(actin-E) which activates expression of Gal4 ubiquitously in the fly (black). Three examples of UAS lines
+
are shown: c) P{UAS-lacZ,w } carries a UAS enhancer in front of the lacZ reporter gene; d) P{UAS+
+
Ubx,w } carries the UAS enhancer in front of the Ubx gene; e) P{EP,w }Ubx is an enhancer-promoter
(EP) line with a random insertion into the Ubx locus at 89D (analogous to enhancer trap line in Fig. 12 A);
P-elements of EP lines carry an UAS enhancer plus basal promoter which, on Gal4 binding, jointly
activate genes that lie downstream of their random insertion sites (here the Ubx gene).
24
e. FRT lines: FRT (FLP recognition target) sites are specifically targeted by the yeast FLP
recombinase ("flippase"). The FLP/FRT system is widely used in Drosophila as an inducible
recombination system that has mostly replaced former X-ray based strategies [14,99]. It is
used to excise genetic material (to activate/inactivate genes or markers) or to cause
somatic recombination between homologous chromosomes, an event that would normally
only occur during meiosis (Fig. 7). Somatic recombination requires specific insertions of FRTbearing P-elements close to the centromere of both homologous chromosomes. At these FRT
sites, FLP will catalyse breakage and exchange of the homologous chromosome arms which
can distribute into different cells in subsequent cell divisions. When starting from heterozygous
individuals, this method can produce mosaic tissues with homozygous clones of cells
surrounded by heterozygous cells [14]. Somatic recombination is used for MARCM (Mosaic
Analysis with a Repressible Cell Marker) analysis studying the behaviour of single mutant
cells or cell groups in normal or mutant tissue [109] (Fig. 15). Another important application is
the generation of germline clones using Flippase/FRT-mediated recombination at the larval
stage. After such animals have developed into female adults, their ovaries contain
homozygous mutant germline stem cells which will give rise to oocytes/embryos without
maternal gene product (maternal mutant; Fig. 16) [31].
Figure 15. Clonal analysis using
MARCM:
A) MARCM scheme: Activation of
UAS-GFP through a tissue-specific
Gal4 driver (blue arrow) is suppressed
(grey T) by the Gal4 inhibitor Gal80
present in heterozygosis on a
chromosome with an FRT site; the
homologous chromosome carries a
mutation of interest and an equivalent
FRT site; activation of Flippase (Flp)
causes somatic recombination at these
FRT sites (red arrows); during
subsequent somatic cell divisions the
mutant allele may assort into the same
daughter cell and become homozygous
(m/m) creating a parallel twin clone
(+/+) that carries both the wildtype
allele and Gal80 in homozygosis.
Subsequent divisions multiply cells with
these
genotypes
embedded
in
heterozygous tissue. B-D) Illustration
for the use of MARCM in research: B)
Image of a normal wing imaginal disc
at the late larval stage displaying blue
marker gene expression along the
antero-posterior
compartment
boundary. C) In larvae carrying a
hypothetical mutation in homozygosis (m/m), wing discs express the marker gene throughout and are
under-grown and aberrant to a degree that no sensible conclusions can be made about the gene's
function. D) Small MARCM clones do not disturb the overall morphology of the wing disc and allow the
study of mutant cells unequivocally identifiable by their GFP-expression (green outline). In this example,
m/m mutant cells away from the compartment boundary display ectopic expression of the blue marker
gene, suggesting that the wildtype M protein negatively regulates expression of the marker gene.
f.
RNAi lines: Application of RNA interference strategies in flies has become a powerful
alternative to the use of mutant alleles. As one key advantage, fly lines carrying UAS-RNAi
constructs (available for virtually every gene) [37,75] allow the targeted knock-down of specific
genes in a reproducible tissue or set of cells, often at distinct stages of development. Like
analyses using mutant FRT-clones (section 5.2e), this approach can therefore overcome
problems caused by systemic loss of gene function, such as early lethality (often impeding
analyses at postembryonic stages) or complex aberrations of whole tissues that can be
25
difficult to interpret. However, the use of RNAi lines needs to be well controlled.
Demonstration of reduced protein or RNA levels of the targeted gene is not sufficient, since
phenotypes can still be due to additional off-target effects (i.e. knock-down of independent
gene functions). Therefore, it is advised to use more than one independent RNAi line targeting
different regions of the gene. Other proof of specificity can come from enhancement of the
knock-down phenotype in the presence of one mutant copy of the targeted gene or, vice
versa, suppression of the knock-down phenotype through co-expression of a rescue construct
for the targeted gene (using the degenerate code to protect rescue RNA from knock-down).
26
an independent reference point, and they can be assessed jointly in the same set of crosses,
thus informing you about the approximate location of your mutation [17,46]. Note that multimarker chromosomes can also be used to generate recombinant chromosomes where other
strategies might fail. For example, recombining a mutation onto a chromosome that already
carries two or more mutations, or making recombinant chromosomes with homozygous viable
mutations is made far easier with multi-marker chromosomes.
st
nd
rd
A homozygous viable transgenic fly line carries a P{lacZ,w } insertion on either 1 , 2 or 3 chromosome
+
(Pw ?). P) To determine the chromosome of insertion, males of this line (paternal chromosomes in blue)
nd
rd
are crossed to a white mutant double-balancer line carrying balancers on both 2 and 3 chromosome
(note, that the same can be done in two parallel crosses to single balancer stocks carrying balancers on
nd
rd
only 2 and only 3 ; try it out!). F1) In the first filial generation potential X chromosome insertions can be
determined; if X is excluded, complementary chromosome combinations are selected for a second cross;
males can be used for the dominant marker combination (If and Ser) since recombination is excluded by
default in males (section 4.1.4.), whereas recombination in the females is suppressed through using the
nd
rd
balancers (CyO and TM3). F2) In the second filial generation, potential 2 or 3 chromosomal insertions
can be determined (note that helpful stocks for follow-up crosses can be selected at this stage, e.g.
+
+
nd
If/CyO;Pw /Pw would facilitate future combinations of the P-element insertion with a mutation on the 2
chromosome); if w/w;If/CyO;Ser/TM3,Sb flies in F2 are still orange, you have a rare event in which your
th
insertion is on the 4 or the Y chromosome.
27
phenotype (e.g. lethality) you can infer that the gene of interest is uncovered by this deficiency
(hemizygous constellation). Note that, when dealing with lethal mutations, only 25% of your
offspring are expected to carry the phenotype, so you look for presence/absence of balancerfree animals in F1 (Fig. 6). Absence of the phenotype excludes the group of genes uncovered
by the deficiency. By using various deficiencies in the area, the mapping of the gene can be
further refined (Fig. 18).
d. Complementation tests with known loss-of-function mutant alleles: Once the location of your
gene has been narrowed down by deletion mapping, you can cross your mutation to available
loss-of-function mutations for the genes in this area, basically following the same strategy as
for deletion mapping. Presence of the phenotype indicates that the mutations are alleles of the
same gene (hetero-allelic constellation). Absence of the phenotype suggests that these
alleles belong to different genes (trans-heterozygous constellation). However, be aware
that the nature of a gene may be complex and lead to false interpretations of your
complementation analysis:
Genes may display transvection, a phenomenon where different homozygous mutant
alleles affecting different areas of the same gene may complement each other [39].
Genes can be nested, i.e. complete genes can be lying within introns of another gene, or
they may map to the complementary strand of DNA at the same locus.
Adjacent genes with separate coding regions might still share common gene regulatory
regions, and therefore display unusual complementation behaviour.
Finally, non-coding RNAs are encoded by independent loci that may often be considered
to represent genes themselves. These loci have important gene regulatory functions and
can complicate the analyses of other genes in their vicinity1.
To circumvent some of these problems, other strategies are available. For example,
collections of UAS-RNAi fly lines (section 5.2f) can be used to systematically knock down
the functions of genes in the area of interest. This strategy only works if your mutation has
phenotypes characteristic enough to be unequivocally identifiable upon gene knock-down.
Furthermore, important clarification can often be obtained from the detailed transcriptional
28
profiles displayed for every gene on FlyBase (at the bottom of the "Expression/Regulation"
view in GBrowse).
29
8. Acknowledgements
I am most grateful to Casey Bergman, Ian Dworkin, Sanjai Patel and John Roote for comments and
feedback on this manual. I would like to thank figshare.com for providing the facilities to upload and
manage this document so easily.
9. References
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
Ahuja A, Singh RS (2008) Variation and evolution of male sex combs in Drosophila: nature of selection
response and theories of genetic variation for sexual traits. Genetics 179: 503-509.
Ashburner M (1993) Epilogue. In: Bate M, Martnez Arias A, editors. The development of Drosophila
melanogaster. Cold Spring Harbor: CSH Laboratory Press. pp. 1493-1506.
Ashburner M, Golic KG, Hawley RS (2005) Drosophila: a laboratory handbook. Cold Spring Harbor,
New York: Cold Spring Harbor Laboratory Press. 1409 p.
Ashburner M, Roote J (2007) Culture of Drosophila: the laboratory setup. CSH Protoc 2007: pdb ip34.
Ashburner M, Roote J (2007) Maintenance of a Drosophila laboratory: general procedures. CSH Protoc
2007: pdb ip35.
Bachmann A, Knust E (2008) The use of P-element transposons to generate transgenic flies. In:
Dahmann C, editor. Drosophila Methods and Protocols. 2008/07/22 ed: Humana Press. pp. 61-77.
Bassett AR, Liu J-L (2014) CRISPR/Cas9 and genome editing in Drosophila. Journal of Genetics and
Genomics 41: 7-19.
Bauerly E, Hughes SE, Vietti DR, Miller DE, McDowell W, et al. (2014) Discovery of supernumerary B
chromosomes in Drosophila melanogaster. Genetics.
Beckingham KM, Armstrong JD, Texada MJ, Munjaal R, Baker DA (2005) Drosophila melanogaster the model organism of choice for the complex biology of multi-cellular organisms. Gravit Space Biol Bull
18: 17-29.
Bellen HJ, Levis RW, He Y, Carlson JW, Evans-Holm M, et al. (2011) The Drosophila gene disruption
project: progress using transposons with distinctive site specificities. Genetics 188: 731-743.
Bellen HJ, O'Kane CJ, Wilson C, Grossniklaus U, Pearson RK, et al. (1989) P-element-mediated
enhancer detection: a versatile method to study development in Drosophila. Genes Dev 3: 1288-1300.
Bellen HJ, Tong C, Tsuda H (2010) 100 years of Drosophila research and its impact on vertebrate
neuroscience: a history lesson for the future. Nat Rev Neurosci 11: 514-522.
Bier E (2005) Drosophila, the golden bug, emerges as a tool for human genetics. Nat Rev Genet 6: 923.
Bischof J, Basler K (2008) Recombinases and their use in gene activation, gene inactivation, and
transgenesis. In: Dahmann C, editor. Drosophila Methods and Protocols. 2008/07/22 ed: Humana
Press. pp. 175-195.
Bischof J, Maeda RK, Hediger M, Karch F, Basler K (2007) An optimized transgenesis system for
Drosophila using germ-line-specific varphiC31 integrases. Proc Natl Acad Sci U S A 104: 3312-3317.
Blumenstiel JP, Noll AC, Griffiths JA, Perera AG, Walton KN, et al. (2009) Identification of EMS-induced
mutations in Drosophila melanogaster by whole-genome sequencing. Genetics 182: 25-32.
Bkel C (2008) EMS screens : from mutagenesis to screening and mapping. In: Dahmann C, editor.
Drosophila Methods and Protocols. 2008/07/22 ed: Humana Press. pp. 119-138.
Bosco G, Campbell P, Leiva-Neto JT, Markow TA (2007) Analysis of Drosophila species genome size
and satellite DNA content reveals significant differences among strains as well as between species.
Genetics 177: 1277-1290.
Bridges CB (1936) D.I.S. work sheet no. 1: external structure of Drosophila. Drosophila Information
Service 6: 76.
Buszczak M, Paterno S, Lighthouse D, Bachman J, Planck J, et al. (2007) The carnegie protein trap
library: a versatile tool for Drosophila developmental studies. Genetics 175: 1505-1531.
Campos-Ortega JA, Hartenstein V (1997) The embryonic development of Drosophila melanogaster.
Berlin: Springer Verlag. 227 p.
Carlson EA (2013) How fruit flies came to launch the chromosome theory of heredity. Mutat Res 753: 16.
Carrera P, Abrell S, Kerber B, Walldorf U, Preiss A, et al. (1998) A modifier screen in the eye reveals
control genes for Krppel activity in the Drosophila embryo. Proc Natl Acad Sci U S A 95: 10779-10784.
Casso D, Ramirez-Weber F, Kornberg TB (2000) GFP-tagged balancer chromosomes for Drosophila
melanogaster. Mech Dev 91: 451-454.
Caussinus E, Kanca O, Affolter M (2012) Fluorescent fusion protein knockout mediated by anti-GFP
nanobody. Nat Struct Mol Biol 19: 117-121.
Chandler CH, Chari S, Dworkin I (2013) Does your gene need a background check? How genetic
background impacts the analysis of mutations, genes, and evolution. Trends in Genetics 29: 358-366.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
30
Chandler CH, Chari S, Tack D, Dworkin I (2013) Causes and consequences of genetic background
effects illuminated by integrative genomic analysis. Genetics.
Chari S, Dworkin I (2013) The conditional nature of genetic interactions: the consequences of wild-type
backgrounds on mutational interactions in a genome-wide modifier screen. PLoS Genet 9: e1003661.
Cherbas L, Gong L (2014) Cell Lines. Methods.
Childress J, Halder G (2008) Appendix: Phenotypic Markers in Drosophila. In: Dahmann C, editor.
Drosophila Methods and Protocols: Humana Press. pp. 27-44.
Chou TB, Perrimon N (1992) Use of a yeast site-specific recombinase to produce female germline
chimeras in Drosophila. Genetics 131: 643-653.
Chyb S, Gompel N (2013) Atlas of Drosophila morphology: wild-type and classical mutants: Academic
Press. 200 p.
Cook RK, Christensen SJ, Deal JA, Coburn RA, Deal ME, et al. (2012) The generation of chromosomal
deletions to provide extensive coverage and subdivision of the Drosophila melanogaster genome.
Genome Biol 13: R21.
Coolon Joseph D, Stevenson Kraig R, McManus CJ, Graveley Brenton R, Wittkopp Patricia J (2012)
Genomic imprinting absent in Drosophila melanogaster adult females. Cell Reports 2: 69-75.
de Belle JS, Heisenberg M (1996) Expression of Drosophila mushroom body mutations in alternative
genetic backgrounds: a case study of the mushroom body miniature gene (mbm). Proc Natl Acad Sci U
S A 93: 9875-9880.
Diegelmann S, Bate M, Landgraf M (2008) Gateway cloning vectors for the LexA-based binary
expression system in Drosophila. Fly (Austin) 2: 236-239.
Dietzl G, Chen D, Schnorrer F, Su KC, Barinova Y, et al. (2007) A genome-wide transgenic RNAi library
for conditional gene inactivation in Drosophila. Nature 448: 151-156.
Dostert C, Jouanguy E, Irving P, Troxler L, Galiana-Arnoux D, et al. (2005) The Jak-STAT signaling
pathway is required but not sufficient for the antiviral response of Drosophila. Nat Immunol 6: 946-953.
Duncan IW (2002) Transvection effects in Drosophila. Annu Rev Genet 36: 521-556.
Elliott DA, Brand AH (2008) The GAL4 system: a versatile system for the expression of genes. In:
Dahmann C, editor. Drosophila Methods and Protocols. 2008/07/22 ed: Humana Press. pp. 79-95.
Emerald BS, Cohen SM (2004) Spatial and temporal regulation of the homeotic selector gene
Antennapedia is required for the establishment of leg identity in Drosophila. Dev Biol 267: 462-472.
Giacomotto J, Segalat L (2010) High-throughput screening and small animal models, where are we? Br
J Pharmacol 160: 204-216.
Gratz SJ, Ukken FP, Rubinstein CD, Thiede G, Donohue LK, et al. (2014) Highly specific and efficient
CRISPR/Cas9-catalyzed
homology-directed
repair
in
Drosophila.
Genetics
10.1534/genetics.113.160713.
Green EW, Fedele G, Giorgini F, Kyriacou CP (2014) A Drosophila RNAi collection is subject to
dominant phenotypic effects. Nat Meth 11: 222-223.
Green MM (2010) 2010: A century of Drosophila genetics through the prism of the white gene. Genetics
184: 3-7.
Greenspan RJ (2004) Fly pushing: The theory and practice of Drosophila genetics. Cold Spring Harbor
New York: Cold Spring Harbor Laboratory Press. 183 p.
Guo A, Li L, Xia SZ, Feng CH, Wolf R, et al. (1996) Conditioned visual flight orientation in Drosophila:
dependence on age, practice, and diet. Learn Mem 3: 49-59.
Halfon MS, Gisselbrecht S, Lu J, Estrada B, Keshishian H, et al. (2002) New fluorescent protein
reporters for use with the Drosophila Gal4 expression system and for vital detection of balancer
chromosomes. Genesis 34: 135-138.
Hartwell LH, Hood L, Goldberg ML, Reynolds AE, Silver LM (2010) Genetics: From Genes to Genomes
(4th edition): McGraw-Hill.
Henderson DS (2004) The chromosomes of Drosophila melanogaster. Methods Mol Biol 247: 1-43.
Hu Y, Flockhart I, Vinayagam A, Bergwitz C, Berger B, et al. (2011) An integrative approach to ortholog
prediction for disease-focused and other functional studies. BMC Bioinformatics 12: 357.
Huang J, Zhou W, Dong W, Watson AM, Hong Y (2009) From the Cover: Directed, efficient, and
versatile modifications of the Drosophila genome by genomic engineering. Proc Natl Acad Sci U S A
106: 8284-8289.
Hummel T, Klambt C (2008) P-element mutagenesis. In: Dahmann C, editor. Drosophila Methods and
Protocols. 2008/07/22 ed: Humana Press. pp. 97-117.
Inagaki HK, Jung Y, Hoopfer ED, Wong AM, Mishra N, et al. (2013) Optogenetic control of Drosophila
using a red-shifted channelrhodopsin reveals experience-dependent influences on courtship. Nat Meth
advance online publication.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
31
Jaiswal M, Sandoval H, Zhang K, Bayat V, Bellen HJ (2012) Probing mechanisms that underlie human
neurodegenerative disease in Drosophila. Annu Rev Genet 46: 371-396.
Kaminker J, Bergman C, Kronmiller B, Carlson J, Svirskas R, et al. (2002) The transposable elements of
the Drosophila melanogaster euchromatin: a genomics perspective. Genome Biology 3:
research0084.0081 - 0084.0020.
Keller EF (1996) Drosophila embryos as transitional objects: the work of Donald Poulson and Christiane
Nusslein-Volhard. Hist Stud Phys Biol Sci 26: 313-346.
Kelso RJ, Buszczak M, Quinones AT, Castiblanco C, Mazzalupo S, et al. (2004) Flytrap, a database
documenting a GFP protein-trap insertion screen in Drosophila melanogaster. Nucleic Acids Res 32
Database issue: D418--D420.
Kelty CM (2012) This is not an article: Model organism newsletters and the question of `open science'.
BioSocieties 7: 140-168.
Kohler RE (1994) Lords of the fly. Drosophila genetics and the experimental life. Chicago, London: The
University of Chicago Press. 321 p.
Kojima T, Ishimaru S, Higashijima S, Takayama E, Akimaru H, et al. (1991) Identification of a differenttype homeobox gene, BarH1, possibly causing Bar (B) and Om(1D) mutations in Drosophila. Proc Natl
Acad Sci U S A 88: 4343-4347.
Kondo T, Sakuma T, Wada H, Akimoto-Kato A, Yamamoto T, et al. (2014) TALEN-induced gene knock
out in Drosophila. Dev Growth Differ 56: 86-91.
Lawrence P (1992) The making of a fly: the genetics of animal design. Oxford: Blackwell Science. 240 p.
Layalle S, Volovitch M, Mugat B, Bonneaud N, Parmentier ML, et al. (2011) Engrailed homeoprotein
acts as a signaling molecule in the developing fly. Development 138: 2315-2323.
Lee WC, Micchelli CA (2013) Development and characterization of a chemically defined food for
Drosophila. PLoS One 8: e67308.
Lindsley DL, Zimm GG (1992) The genome of Drosophila melanogaster: Academic Press. 1133 p.
Lipshitz HD (2005) From fruit flies to fallout: Ed Lewis and his science. Dev Dyn 232: 529-546.
Liu J, Li C, Yu Z, Huang P, Wu H, et al. (2012) Efficient and specific modifications of the Drosophila
genome by means of an easy TALEN strategy. J Genet Genomics 39: 209-215.
Mackay TF, Richards S, Stone EA, Barbadilla A, Ayroles JF, et al. (2012) The Drosophila melanogaster
genetic reference panel. Nature 482: 173-178.
Maggert KA, Gong WJ, Golic KG (2008) Methods for homologous recombination in Drosophila. In:
Dahmann C, editor. Drosophila Methods and Protocols. 2008/07/22 ed: Humana Press. pp. 155-174.
Magwire MM, Fabian DK, Schweyen H, Cao C, Longdon B, et al. (2012) Genome-wide association
studies reveal a simple genetic basis of resistance to naturally coevolving viruses in Drosophila
melanogaster. PLoS Genet 8: e1003057.
Martinez Arias A (2008) Drosophila melanogaster and the development of biology in the 20th century.
In: Dahmann C, editor. Drosophila Methods and Protocols. 2008/07/22 ed: Humana Press. pp. 1-25.
Matthews KA, Kaufman TC, Gelbart WM (2005) Research resources for Drosophila: the expanding
universe. Nat Rev Genet 6: 179-193.
Miller WJ (2013) Bugs in transition: the dynamic world of Wolbachia in insects. PLoS Genet 9:
e1004069.
Ni JQ, Liu LP, Binari R, Hardy R, Shim HS, et al. (2009) A Drosophila resource of transgenic RNAi lines
for neurogenetics. Genetics 182: 1089-1100.
Pfeiffer BD, Ngo T-TB, Hibbard KL, Murphy C, Jenett A, et al. (2010) Refinement of Tools for Targeted
Gene Expression in Drosophila. Genetics 186: 735-755.
Pfeiffer BD, Truman JW, Rubin GM (2012) Using translational enhancers to increase transgene
expression in Drosophila. Proc Natl Acad Sci U S A 109: 6626-6631.
Piper MD, Blanc E, Leitao-Goncalves R, Yang M, He X, et al. (2014) A holidic medium for Drosophila
melanogaster. Nat Methods 11: 100-105.
Potter CJ, Luo L (2010) Splinkerette PCR for mapping transposable elements in Drosophila. PLoS One
5: e10168.
Prokop A, Bray S, Harrison E, Technau GM (1998) Homeotic regulation of segment-specific differences
in neuroblast numbers and proliferation in the Drosophila central nervous system. Mech Dev 74: 99-110.
Prokop A, Kppers-Munther B, Snchez-Soriano N (2012) Using primary neuron cultures of Drosophila
to analyse neuronal circuit formation and function. In: Hassan BA, editor. The making and un-making of
neuronal circuits in Drosophila. New York: Humana Press. pp. 225-247.
Rand DM, Fry A, Sheldahl L (2006) Nuclearmitochondrial epistasis and Drosophila aging: introgression
of Drosophila simulans mtDNA modifies longevity in D. melanogaster nuclear backgrounds. Genetics
172: 329-341.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
32
33
For this, you start by crossing ry females with e males or vice versa (P, parental cross). In the first
filial generation (F1), all flies are trans-heterozygous (ry,+/+,e). Note that the different fly stocks
used in this cross will be colour-coded to allow you to easily trace the origin of each chromosome.
According to the recombination rule, you need to take females so that recombination can occur.
Note that crossing-over during oogenesis in these females occurs at random, i.e. their eggs which
give rise to the second filial generation (F2) represent a cocktail of recombination events with a
statistical likelihood of 18.7% as calculated above. Note that only half of the tested animals carry
the first marker ry, out of which only 18.7% display the wanted recombination. Therefore, 9.35% of
the single F2 individuals carry a recombinant chromosome with both markers, and 9.35% a
recombinant chromosome with wildtype alleles of both markers. The key task is to identify and
isolate these recombination events through a step-wise process.
In the first step, recombination events need to be "stabilised" to prevent further recombination. For
this, F1 females are crossed to a balancer stock carrying a balancer chromosome (Bal1) over a
dominantly marked chromosome (M1; sections 4.2. and 4.3). In the third filial generation (F3), you
determine whether one of the markers (here ry) is present (remember that, according to the law of
segregation, only 50% of balanced F2 individuals carry ry). To determine the presence of ry, you
cross F2 animals back to a ry mutant stock. Two important issues need to be considered here.
Firstly, each individual in F2 is the result of an individual recombination event in its mother's
germline. Therefore, single animals need to be tested for the presence of ry. For practical
reasons, use single males since they can fertilise several females and therefore have a higher
likelihood to generate enough offspring.
34
Secondly, you have to cross back to ry mutant flies, but need to be able to distinguish your
recombinant chromosome from the ry chromosome of the back-cross. For this, cross the ry
stock to a balancer stock (Bal2) that can be distinguished from Bal1.
In F3, use simple selection to separate out two groups of flies: non-balanced flies allow you to
determine whether flies have brownish eyes (i.e. carry ry on their potentially recombinant
chromosome). If this is the case, flies carrying Bal2 over the potentially recombinant paternal
chromosome (rather than the ry chromosome of their mothers) can be used to establish a stable fly
stock. The fourth filial generation (F4) emerging from these newly established fly stocks will contain
non-balanced animals (ry and e are viable mutations). Stocks in which non-balanced flies have
brownish eyes and dark body colour bear the desired recombinant chromosome and will be kept,
the rest discarded.
For consideration:
To have a statistical chance of isolating recombination events, more than 10 single crosses in F2
should be used to match the 9.35% chance of obtaining a recombinant.
The example of ry and e represents an unusual case, since they are common marker mutations that
are found on several balancer chromosomes (section 4.3.). Using balancers with these markers would
allow you to immediately identify the presence of the desired mutations on the potentially recombinant
chromosomes. Try it yourself.
35
nd
Example of a trihybrid cross between heterozygous parents (P, top) involving recessive alleles on X, 2 and
rd
3 chromosomes (separated by semicolons). Homologous alleles are separated by a horizontal line; maternal
alleles are shown in black, paternal ones in blue. Mutant alleles are w (white; white eyes), vg (vestigial;
reduced wings), e (ebony; dark body colour); phenotypes are indicated by fly diagrams (compare Fig. 9). In
the first offspring/filial generation (F1) each chromosome has undergone independent assortment of alleles
(demarcated by curly brackets) and each of the four possible outcomes per chromosome can be combined
with any of the outcomes of the other two chromosomes resulting in 4 x 4 x 4 = 64 combinations. The Punnett
square at the bottom systematically lists all possible combinations (different phenotype classes are colourcoded and display a 18:18:6:6:6:6:2:2 distribution; symbols are explained at the bottom). Red and blue
stippled boxes show the same examples of two possible offspring in both the curly bracket scheme and the
Punnett square. Note that the Punnett square reflects the numerical outcome of this cross in its full
complexity, whereas the curly bracket strategy only qualitatively reflects potential combinations and is easier
to interpret for the purpose of mating scheme design (Box 9).